These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 7346748)

  • 1. Pharmacokinetics and relative bioavailability of intramuscular phenobarbital sodium or acid in infants.
    Minagawa K; Miura H; Chiba K; Ishizaki T
    Pediatr Pharmacol (New York); 1981; 1(4):279-89. PubMed ID: 7346748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma and cerebrospinal fluid concentrations of phenobarbital in infants given single doses.
    Jalling B
    Dev Med Child Neurol; 1974 Dec; 16(6):781-93. PubMed ID: 4442659
    [No Abstract]   [Full Text] [Related]  

  • 3. Phenobarbital in the acute management of febrile convulsions.
    Pearce JL; Sharman JR; Forster RM
    Pediatrics; 1977 Oct; 60(4 Pt 2):569-72. PubMed ID: 263268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacokinetics of injectable phenobarbital in the premature infant. Study of a new lyophilized form].
    Kossmann JC; Ribon B; Claris O; Brazier JL; Salle B
    Arch Fr Pediatr; 1985 Apr; 42(4):317-20. PubMed ID: 4004495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absorption of phenobarbital after the intramuscular administration of single doses in infants.
    Brachet-Liermain A; Goutieres F; Aicardi J
    J Pediatr; 1975 Oct; 87(4):624-6. PubMed ID: 1159593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suprofen kinetics in healthy male volunteers after intramuscular injection of increasing dosages.
    Zulliger HW; Fassolt A
    Arzneimittelforschung; 1983; 33(9):1322-6. PubMed ID: 6685517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and intramuscular bioavailability of cefuroxime sodium in goats.
    ABO EL-SOOUD K; El-Banna HA; Hanafy MS; Goudah A
    Res Vet Sci; 2000 Dec; 69(3):219-24. PubMed ID: 11124092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions.
    Pépin-Covatta S; Lutsch C; Grandgeorge M; Lang J; Scherrmann JM
    Toxicol Appl Pharmacol; 1996 Nov; 141(1):272-7. PubMed ID: 8917700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics, intramuscular bioavailability and tissue residue profiles of ceftazidime in a rabbit model.
    Abd El-Aty AM; Goudah A; Abo El Sooud K
    Dtsch Tierarztl Wochenschr; 2001 Apr; 108(4):168-71. PubMed ID: 11370478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTP toxicity studies of carisoprodol (CAS No. 78-44-4) administered by Gavage to F344/N rats and B6C3F1 mice.
    Chan PC
    Toxic Rep Ser; 2000 Aug; (56):1-G14. PubMed ID: 11986679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bioavailability of phenytoin acid and phenytoin sodium with enteral feedings.
    Doak KK; Haas CE; Dunnigan KJ; Reiss RA; Reiser JR; Huntress J; Altavela JL
    Pharmacotherapy; 1998; 18(3):637-45. PubMed ID: 9620116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioavailability of phenobarbital by rectal administration.
    Matsukura M; Higashi A; Ikeda T; Matsuda I
    Pediatr Pharmacol (New York); 1981; 1(3):259-65. PubMed ID: 7346746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single- and repeated-dose pharmacokinetics of intramuscular thiocolchicoside in healthy volunteers.
    Weinling E; Sandouk P; Debray M; Scherrmann JM
    Int J Clin Pharmacol Ther; 1999 Oct; 37(10):503-9. PubMed ID: 10543318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prevention of hypoxic-ischemic encephalopathy with high-dose, early phenobarbital therapy].
    Vargas-Origel A; Espinosa-García JO; Muñiz-Quezada E; Vargas-Nieto MA; Aguilar-García G
    Gac Med Mex; 2004; 140(2):147-53. PubMed ID: 15162947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetic investigation of phenobarbital by mixed effect modelling using routine clinical pharmacokinetic data in Japanese neonates and infants.
    Yukawa E; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2005 Apr; 30(2):159-63. PubMed ID: 15811169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenobarbital for treatment of seizures in preterm infant: a new administration scheme.
    De Carolis MP; Muzii U; Romagnoli C; Zuppa AA; Zecca E; Tortorolo G
    Dev Pharmacol Ther; 1989; 14(2):84-9. PubMed ID: 2630236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of the absorption of phenobarbitone given via the oral and the intramuscular route.
    Graham JK
    Clin Exp Neurol; 1978; 15():154-8. PubMed ID: 756010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.